← Leaderboards
Jimmy Zhang
University Of Rochester
$124,433
Attributed
$124,433
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$124,433 · 1
By mechanism
F30$124,433 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Paul S Brookes$10,286,136
- Eric M Small$9,887,143
- Keith W Nehrke$7,086,980
- Nazzareno Ballatori$15,093,883
- Mark E. Dumont$10,787,618
Others in their field
Other Emerging Leaders on “Infarction”
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
- Vera Hoffman · Reveal Pharma$8,460,813
- Jose Gutierrez · Columbia University Health Sciences$7,601,653
- Wuqiang Zhu · Mayo Clinic Arizona$6,493,351
- Michelle Meyer · Univ Of North Carolina Chapel Hill$6,020,048
- Xuefang Sophie Ren · University Of Texas Hlth Sci Ctr Houston$5,892,622
Research focus
InfarctionAcute Myocardial InfarctionBlood FlowAreaCardiac MyocytesAutomobile DrivingCardiotonic AgentsCell DeathCardiacCollectionComplexConsumptionCoronary VesselsElectron TransportEventFaceGenerationsGlutathioneHeartClinically RelevantHeart MetabolismHigh Throughput ScreeningHypoxiaInjury
Grant awards (3)
The Development of Novel Acute Myocardial Infarction Therapeutics Using Metabolomics and High-Throughput Screening$25,865
F30 · FY2019 · HL · contact PI
The Development of Novel Acute Myocardial Infarction Therapeutics Using Metabolomics and High-Throughput Screening$49,524
F30 · FY2018 · HL · contact PI
The Development of Novel Acute Myocardial Infarction Therapeutics Using Metabolomics and High-Throughput Screening$49,044
F30 · FY2017 · HL · contact PI